UPC CFI 195/2025

At the UPC: Sanofi Group (33 cases)·Amgen Group (19 cases)

• 2026-06-08
  Infringement ActionPublic

  Summary: Both the claimants' infringement action and the defendants' counterclaim for revocation were withdrawn before closure of the written procedure. The court permitted both withdrawals, declared proceedings closed, and ordered 50% reimbursement of court fees to both parties.

  Show the legal issues (4)

  • Withdrawal of infringement action (R. 265 RoP)
  • Withdrawal of counterclaim for revocation
  • Reimbursement of court fees on withdrawal (R. 370.9 RoP)
  • Lifting of stay of proceedings
• 2025-08-06
  Public

  Summary: The Düsseldorf Local Division granted the claimants' request to stay infringement proceedings (and the related counterclaim for revocation) concerning EP 4 252 857 pending the outcome of the appeal against the first-instance decision in related case UPC_CFI_505/2024 (concerning EP 3 536 712). The court found that both cases involve the same factual and legal infringement questions and that a stay serves efficient use of judicial and party resources.

  Show the legal issues (3)

  • Stay of proceedings (R. 295(m) RoP)
  • Related infringement proceedings involving same legal and factual questions
  • Efficient administration of justice